Laddar...
Immunotherapy updates in pancreatic cancer: are we there yet?
Pancreatic cancer is a lethal disease and remains one of the most resistant cancers to traditional therapies. Historically, chemotherapy or radiotherapy did not provide meaningful survival benefit in advanced pancreatic cancer. Gemcitabine and recently FOLFIRINOX (5-flourouracil, leucovorin, oxalipl...
Sparad:
| Huvudupphovsmän: | , , |
|---|---|
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
SAGE Publications
2013
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3539275/ https://ncbi.nlm.nih.gov/pubmed/23323149 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758834012462463 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|